Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2597)
All Articles published online
|
Jul 7, 2005 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lü ZL, Luo DZ, Wen JM. Expression and significance of tumor-related genes in HCC. World J Gastroenterol 2005; 11(25): 3850-3854 [PMID: 15991281 DOI: 10.3748/wjg.v11.i25.3850] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i25/3850.htm |
| Number | Citing Articles |
| 1 |
Taofic Mounajjed, Lizhi Zhang, Tsung-Teh Wu. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms. Human Pathology 2013; 44(4): 542 doi: 10.1016/j.humpath.2012.06.016
|
| 2 |
Hicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, Amrathlal Rabbind Singh, Christèle Ossart, Aline Reignier, Hakim Hocini, Gregory Fouquet, Mohammed Al Baghami, Mélanie Simoes Eugenio, Eric Nguyen-Khac, Jean-Marc Regimbeau, Ingrid Marcq. RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation. Oncotarget 2016; 7(9): 9832 doi: 10.18632/oncotarget.6954
|
| 3 |
Tomomi Masuda, Eiji Miyoshi. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics. cclm 2011; 49(6): 959 doi: 10.1515/CCLM.2011.152
|
| 4 |
Azza E El Bassiouny, Mona M Nosseir, Mona K Zoheiry, Noha A Ameen, Ahmed M Abdel-Hadi, Ibrahim M Ibrahim, Suher Zada, Abdel-Hakeem Saad El-Deen, Nora E El-Bassiouni. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World Journal of Hepatology 2010; 2(1): 32-41 doi: 10.4254/wjh.v2.i1.32
|
| 5 |
Benjamin A. Weinberg, Hongkun Wang, Agnieszka K. Witkiewicz, John L. Marshall, Aiwu R. He, Paris Vail, Erik S. Knudsen, Michael J. Pishvaian. A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy. Journal of Pancreatic Cancer 2020; 6(1): 45 doi: 10.1089/pancan.2020.0005
|
| 6 |
Yanan Zhang, Jie Liu, Shibin Wang, Xiaoli Luo, Yang Li, Zhaohui Lv, Jie Zhu, Jing Lin, Lihua Ding, Qinong Ye. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners. Oncotarget 2016; 7(17): 23740 doi: 10.18632/oncotarget.8060
|
| 7 |
Yuexiang Niu, Engong Tang, Qingan Zhang. Cytotoxic effect of silica nanoparticles against hepatocellular carcinoma cells through necroptosis induction. Toxicology Research 2019; 8(6): 1042 doi: 10.1039/c9tx00240e
|
| 8 |
Hong Seok Jang, Ki Mun Kang, Byung Ock Choi, Gyu Young Chai, Soon Chan Hong, Woo Song Ha, Randy L Jirtle. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(9): 1394-1398 doi: 10.3748/wjg.14.1394
|
| 9 |
Asako Kimura, Kazuyuki Sogawa, Mamoru Satoh, Yoshio Kodera, Osamu Yokosuka, Takeshi Tomonaga, Fumio Nomura. The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma. International Journal of Proteomics 2012; 2012: 1 doi: 10.1155/2012/623190
|
| 10 |
Sonja M. Kessler, Alexandra K. Kiemer. Mechanisms of Molecular Carcinogenesis – Volume 1. 2017; : 61 doi: 10.1007/978-3-319-53659-0_4
|
| 11 |
Susan C. Tilton, Lena G. Gerwick, Jerry D. Hendricks, Caprice S. Rosato, Graham Corley-Smith, Scott A. Givan, George S. Bailey, Christopher J. Bayne, David E. Williams. Use of a Rainbow Trout Oligonucleotide Microarray to Determine Transcriptional Patterns in Aflatoxin B1-Induced Hepatocellular Carcinoma Compared to Adjacent Liver. Toxicological Sciences 2005; 88(2): 319 doi: 10.1093/toxsci/kfi309
|
| 12 |
Le Yu, Xiaobin Huang, Wenfa Zhang, Huakan Zhao, Gang Wu, Fenglin Lv, Lei Shi, Yong Teng. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget 2016; 7(18): 26844 doi: 10.18632/oncotarget.8565
|
| 13 |
Sevcan ATAY. Hepatit-B virüs ilişkili hepatosellüler karsinomda tümöral glipikan 3 mRNA seviyesinin diagnostik ve prognostik biyobelirteç olabilme potansiyelinin entegratif transkriptomik meta-analiz ve biyoinformatik ile değerlendirilmesi. Ege Tıp Dergisi 2022; 61(2): 249 doi: 10.19161/etd.1127225
|
| 14 |
Sonja M. Kessler, Juliane Pokorny, Vincent Zimmer, Stephan Laggai, Frank Lammert, Rainer M. Bohle, Alexandra K. Kiemer. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(4): G328 doi: 10.1152/ajpgi.00005.2012
|
| 15 |
HUO-CHUN YI, YA-LI LIU, PAN YOU, JIN-SHUI PAN, JIAN-YAN ZHOU, ZHEN-JIN LIU, ZHONG-YING ZHANG. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma. Molecular Medicine Reports 2015; 11(2): 1318 doi: 10.3892/mmr.2014.2781
|
| 16 |
Gokce Askan, Vikram Deshpande, David S. Klimstra, Volkan Adsay, Carlie Sigel, Jinru Shia, Olca Basturk. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms. American Journal of Clinical Pathology 2016; 146(2): 163 doi: 10.1093/ajcp/aqw096
|
| 17 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
| 18 |
A K Adams, G E Hallenbeck, K A Casper, Y J Patil, K M Wilson, R J Kimple, P F Lambert, D P Witte, W Xiao, M L Gillison, K A Wikenheiser-Brokamp, T M Wise-Draper, S I Wells. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation. Oncogene 2015; 34(7): 868 doi: 10.1038/onc.2014.15
|
| 19 |
Yuyang Liu, Dan Wang, Yongguo Li, Shaoying Yan, Hao Dang, Huan Yue, Jiaji Ling, Fengjiao Chen, Yannan Zhao, Luxia Gou, Ping Tang, Ailong Huang, Hua Tang. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. Experimental Cell Research 2019; 379(1): 19 doi: 10.1016/j.yexcr.2019.03.029
|
| 20 |
Gehan H. Ibrahim, Moushira A. Mahmoud, Nagwa M. Aly. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients. Molecular Biology Reports 2013; 40(12): 7069 doi: 10.1007/s11033-013-2829-3
|
| 21 |
Ming-Xu Qiao, Chun Li, Ai-Qun Zhang, Ling-Ling Hou, Juan Yang, Hong-Gang Hu. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma. Oncology Reports 2016; 36(4): 2382 doi: 10.3892/or.2016.4984
|
| 22 |
Guoliang Liu, Xiaodong Huang, Xiaopeng Cui, Jing Zhang, Lixian Wei, Runzhou Ni, Cuihua Lu. High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma. Medical Oncology 2013; 30(3) doi: 10.1007/s12032-013-0537-4
|
| 23 |
L M Privette Vinnedge, R McClaine, P K Wagh, K A Wikenheiser-Brokamp, S E Waltz, S I Wells. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer. Oncogene 2011; 30(24): 2741 doi: 10.1038/onc.2011.2
|
| 24 |
Jing Wang, Jia Li, Liping Chen, Zhenyu Fan, Jilin Cheng. MicroRNA-499 Suppresses the Growth of Hepatocellular Carcinoma by Downregulating Astrocyte Elevated Gene-1. Technology in Cancer Research & Treatment 2020; 19: 153303382092025 doi: 10.1177/1533033820920253
|
| 25 |
Ella Bowles, Timothy W. Corson, Jane Bayani, Jeremy A. Squire, Nathalie Wong, Paul B.‐S. Lai, Brenda L. Gallie. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes, Chromosomes and Cancer 2007; 46(2): 118 doi: 10.1002/gcc.20383
|
| 26 |
Trisha M. Wise-Draper, Richard J. Morreale, Teresa A. Morris, Rachael A. Mintz-Cole, Elizabeth E. Hoskins, Scott J. Balsitis, Nader Husseinzadeh, David P. Witte, Kathryn A. Wikenheiser-Brokamp, Paul F. Lambert, Susanne I. Wells. DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program. The American Journal of Pathology 2009; 174(1): 71 doi: 10.2353/ajpath.2009.080330
|
| 27 |
Komkrit Ruangritchankul, Ann Sandison. DEK::AFF2 Fusion Carcinomas of Head and Neck. Advances in Anatomic Pathology 2023; 30(2): 86 doi: 10.1097/PAP.0000000000000376
|